Table 1.
Demographic and clinical characteristics of the study cohort.
| Age: x̅ ± SD | 65–74 years old (n = 2555) 69 ± 2.83 |
75–84 years old (n = 2490) 79 ± 2.88 |
≥85 years old (n = 1777) 89 ± 3.62 |
All patients (n = 6822) 78.3 ± 8.30 |
|---|---|---|---|---|
| Men (%) | 1456 (57%) | 1294 (52%) | 649 (36%) | 3439 (50.4%) |
| Women (%) | 1098 (43%) | 1196 (48%) | 1128 (64%) | 3383 (49.6%) |
| Hs-cTnT ng/L (x̅ ± SD) | 93 ± 312.15 | 77 ± 234.46 | 63 ± 162.73 | 79 ± 252.14 |
| Men | 104 ± 353.0 | 80 ± 183.73 | 70 ± 125.32 | 89 ± 264.64 |
| Women | 78 ± 242.34 | 74 ± 279.19 | 59 ± 180.71 | 70 ± 238.45 |
| Comorbidities (N, %) | ||||
| Quartile I (1291, 19.4) | ||||
| Men | 283.48 | 228.52 | 132.61 | 643.48 |
| Women | 349.52 | 207.48 | 83.49 | 684.52 |
| Quartile II (1048, 15.4) | ||||
| Men | 169.39 | 188.48 | 149.58 | 506.48 |
| Women | 263.61 | 204.52 | 78.42 | 545.52 |
| Quartile III (2030, 19.8) | ||||
| Men | 313.41 | 355.48 | 354.67 | 1022.51 |
| Women | 442.59 | 392.52 | 174.33 | 1008.49 |
| Quartile IV (2414, 35.4) | ||||
| Men | 294.43 | 425.46 | 493.61 | 1212.51 |
| Women | 397.56 | 491.54 | 314.39 | 1202.49 |
Hs-cTnT (High-sensitivity cardiac Troponin T), ng/L = nanogram/L Quartiles (I = 1–2 comorbidities, II = 3 comorbidities, III = 4–5 comorbidities, IV = ≥6 comorbidities).